Rino Stocco

3.9k total citations
30 papers, 1.1k citations indexed

About

Rino Stocco is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Rino Stocco has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Pharmacology. Recurrent topics in Rino Stocco's work include Receptor Mechanisms and Signaling (11 papers), Inflammatory mediators and NSAID effects (8 papers) and Asthma and respiratory diseases (6 papers). Rino Stocco is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Inflammatory mediators and NSAID effects (8 papers) and Asthma and respiratory diseases (6 papers). Rino Stocco collaborates with scholars based in Canada, United States and Japan. Rino Stocco's co-authors include Mark Abramovitz, Nicole Sawyer, Mark Ungrin, Deborah Slipetz, Kathleen M. Metters, Shi‐Hsiang Shen, Denis Banville, Yves Boie, Frank Neuschäfer‐Rube and Gerhard P. Püschel and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Cancer Research.

In The Last Decade

Rino Stocco

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rino Stocco Canada 19 455 334 267 260 157 30 1.1k
Chinh Bach United States 12 707 1.6× 315 0.9× 440 1.6× 143 0.6× 160 1.0× 14 1.4k
Toyomichi Nanayama Japan 12 406 0.9× 307 0.9× 260 1.0× 293 1.1× 81 0.5× 20 978
Cornelia Heindl Germany 12 556 1.2× 193 0.6× 447 1.7× 424 1.6× 55 0.4× 17 1.3k
Anne Châteauneuf Canada 13 480 1.1× 261 0.8× 248 0.9× 279 1.1× 133 0.8× 13 1.1k
Noriaki Nakatani Japan 13 650 1.4× 117 0.4× 189 0.7× 251 1.0× 196 1.2× 15 1.3k
Phong Nguyen United States 23 539 1.2× 98 0.3× 106 0.4× 200 0.8× 85 0.5× 51 1.2k
Kim O’Neill United States 16 384 0.8× 148 0.4× 129 0.5× 146 0.6× 122 0.8× 30 1.2k
Toshiya Ogorochi Japan 15 395 0.9× 229 0.7× 138 0.5× 159 0.6× 377 2.4× 15 1.2k
Yasuhide Morioka Japan 19 392 0.9× 201 0.6× 133 0.5× 193 0.7× 110 0.7× 50 973
Tsukasa Sugo Japan 14 615 1.4× 317 0.9× 216 0.8× 151 0.6× 102 0.6× 20 1.3k

Countries citing papers authored by Rino Stocco

Since Specialization
Citations

This map shows the geographic impact of Rino Stocco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rino Stocco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rino Stocco more than expected).

Fields of papers citing papers by Rino Stocco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rino Stocco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rino Stocco. The network helps show where Rino Stocco may publish in the future.

Co-authorship network of co-authors of Rino Stocco

This figure shows the co-authorship network connecting the top 25 collaborators of Rino Stocco. A scholar is included among the top collaborators of Rino Stocco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rino Stocco. Rino Stocco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gallo, David A., Marc L. Hyer, Giovanni Martino, et al.. (2023). Abstract B057: Preclinical development of PKMYT1 and ATR inhibitor combinations. Molecular Cancer Therapeutics. 22(12_Supplement). B057–B057. 1 indexed citations
2.
Hyer, Marc L., David A. Gallo, Vivek Bhaskaran, et al.. (2023). Abstract C163: KRAS alterations combined with TP53 mutations as novel synthetic lethal genomic lesions for PKMYT1 inhibition. Molecular Cancer Therapeutics. 22(12_Supplement). C163–C163. 2 indexed citations
3.
Gallo, David A., Fenil Shah, Rino Stocco, et al.. (2023). Abstract A023: Preclinical development of PKMYT1 and WEE1 inhibitor combinations. Molecular Cancer Therapeutics. 22(12_Supplement). A023–A023. 2 indexed citations
4.
Boyd, Michael J., John Colucci, Carl Berthelette, et al.. (2011). New indole amide derivatives as potent CRTH2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(11). 3471–3474. 15 indexed citations
5.
Leblanc, Yves, Carl Berthelette, Carmela Molinaro, et al.. (2010). Azaindoles as potent CRTH2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(2). 841–845. 21 indexed citations
6.
Melamed, Jeffrey Y., Nathan R. Kett, Anthony L. Gotter, et al.. (2010). Synthesis and evaluation of a new series of Neuropeptide S receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20(15). 4700–4703. 21 indexed citations
7.
Trotter, B. Wesley, Kausik K. Nanda, Peter J. Manley, et al.. (2010). Tricyclic imidazole antagonists of the Neuropeptide S Receptor. Bioorganic & Medicinal Chemistry Letters. 20(15). 4704–4708. 19 indexed citations
8.
Colucci, John, Michael J. Boyd, Carl Berthelette, et al.. (2010). Discovery of 4-{1-[({1-[4-(trifluoromethyl)benzyl]-1H-indol-7-yl}carbonyl)amino]cyclopropyl}benzoic acid (MF-766), a highly potent and selective EP4 antagonist for treating inflammatory pain. Bioorganic & Medicinal Chemistry Letters. 20(12). 3760–3763. 29 indexed citations
9.
Dong, Yan, Rino Stocco, Nicole Sawyer, et al.. (2010). Differential Signaling of Cysteinyl Leukotrienes and a Novel Cysteinyl Leukotriene Receptor 2 (CysLT2) Agonist, N-Methyl-Leukotriene C4, in Calcium Reporter and β Arrestin Assays. Molecular Pharmacology. 79(2). 270–278. 21 indexed citations
10.
Therien, Alex G., Virginie Bernier, Sean Weicker, et al.. (2008). Adenovirus IL-13–Induced Airway Disease in Mice. American Journal of Respiratory Cell and Molecular Biology. 39(1). 26–35. 31 indexed citations
11.
Allen, Irving C., Amy J. Pace, Leigh A. Jania, et al.. (2006). Expression and function of NPSR1/GPRA in the lung before and after induction of asthma-like disease. American Journal of Physiology-Lung Cellular and Molecular Physiology. 291(5). L1005–L1017. 53 indexed citations
12.
Ungrin, Mark, Marie‐Claude Carrière, Danielle Denis, et al.. (2001). Key Structural Features of Prostaglandin E2and Prostanoid Analogs Involved in Binding and Activation of the Human EP1Prostanoid Receptor. Molecular Pharmacology. 59(6). 1446–1456. 49 indexed citations
13.
14.
Durocher, Yves, Sylvie Perret, Marie-Hélène Gaumond, et al.. (2000). A Reporter Gene Assay for High-Throughput Screening of G-Protein-Coupled Receptors Stably or Transiently Expressed in HEK293 EBNA Cells Grown in Suspension Culture. Analytical Biochemistry. 284(2). 316–326. 91 indexed citations
15.
Boie, Yves, Rino Stocco, Nicole Sawyer, et al.. (1999). Characterization of the cloned guinea pig leukotriene B4 receptor: comparison to its human orthologue. European Journal of Pharmacology. 380(2-3). 203–213. 21 indexed citations
16.
Ungrin, Mark, et al.. (1999). An Automated Aequorin Luminescence-Based Functional Calcium Assay for G-Protein-Coupled Receptors. Analytical Biochemistry. 272(1). 34–42. 43 indexed citations
17.
Ruel, Réjean, Mark Abramovitz, Claude Godbout, et al.. (1999). New class of biphenylene dibenzazocinones as potent ligands for the human EP1 prostanoid receptor. Bioorganic & Medicinal Chemistry Letters. 9(18). 2699–2704. 18 indexed citations
18.
Boie, Yves, Rino Stocco, Nicole Sawyer, et al.. (1997). Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. European Journal of Pharmacology. 340(2-3). 227–241. 259 indexed citations
19.
L’Abbé, Denis, Denis Banville, Yiai Tong, et al.. (1994). Identification of a novel protein tyrosine phosphatase with sequence homology to the cytoskeletal proteins of the band 4.1 family. FEBS Letters. 356(2-3). 351–356. 16 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chinh Bach Breakdown of academic impact, for papers by Toyomichi Nanayama Breakdown of academic impact, for papers by Cornelia Heindl Breakdown of academic impact, for papers by Anne Châteauneuf Breakdown of academic impact, for papers by Noriaki Nakatani Breakdown of academic impact, for papers by Phong Nguyen Breakdown of academic impact, for papers by Kim O’Neill Breakdown of academic impact, for papers by Toshiya Ogorochi Breakdown of academic impact, for papers by Yasuhide Morioka Breakdown of academic impact, for papers by Tsukasa Sugo
Rankless by CCL
2026